Trial Profile
A multicentric analysis of the long term efficacy of rituximab in patients with systemic sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Systemic scleroderma
- Focus Therapeutic Use
- 22 Jun 2015 New trial record